-
-
Call more information
660-596-2224 -
Authors: T. Andrew Bowdle, M.D., Ph.D., F.A.S.E. et al Anesthesiology 8 2016, Vol.125, 429-431. To the Editor: The recent article by Nanji et al.1 concerning errors related to anesthetic drug administration is interesting and raises a number of provocative questions. However, we are concerned that the manner in which the data are presented and interpreted may lead readers […]
Read MoreAuthors: Peter A. Chin, M.B.B.S. Anesthesiology 8 2016, Vol.125, 425. To the Editor: I read with interest the report by Beach et al.1 on the relationship between nil per os (NPO) time and major adverse events, with special attention to pulmonary aspiration. The authors conclude that NPO status is not an independent predictor of major complications. As reported […]
Read MoreAuthors: Harsha Shanthanna, M.D. et al Anesthesiology 8 2016, Vol.125, 423-425. To the Editor: We read with interest the study by Turan et al.1 on the use of methylprednisolone for persistent incisional pain after cardiac surgery. This substudy was done on 1,110 of the 7,500 patients included for the Steroid In caRdiac Surgery (SIRS) trial.2 The treatment group […]
Read MoreAuthors: Usman Ali, M.B.B.S., B.Sc., F.R.C.A. et al Anesthesiology 8 2016, Vol.125, 419-420. To the Editor: We read with great interest the article by Wigmore et al.1 The authors have produced one of the largest studies published looking at cancer survival and anesthesia. In an era where new cancer therapies are becoming ever more expensive to develop, their […]
Read MoreAuthors: Sarah A. Dawson, M.B.B.S. Anesthesiology 8 2016, Vol.125, 418-419. To the Editor: I read with great interest the article by Wigmore et al.1 at the Royal Marsden Hospital (London, United Kingdom), which suggested that total intravenous anesthesia (TIVA) is associated with improved cancer survival when compared to volatile inhalational anesthesia. The study has caused a great deal […]
Read More